Sales rise 34.72% to Rs 652.24 crore
Net profit of Glenmark Pharmaceuticals rose 78.60% to Rs 151.67 crore in the quarter ended March 2014 as against Rs 84.92 crore during the previous quarter ended March 2013. Sales rose 34.72% to Rs 652.24 crore in the quarter ended March 2014 as against Rs 484.14 crore during the previous quarter ended March 2013.For the full year,net profit rose 12.36% to Rs 433.82 crore in the year ended March 2014 as against Rs 386.11 crore during the previous year ended March 2013. Sales rose 17.48% to Rs 2273.56 crore in the year ended March 2014 as against Rs 1935.29 crore during the previous year ended March 2013.
ParticularsQuarter EndedYear EndedMar. 2014Mar. 2013% Var.Mar. 2014Mar. 2013% Var.Sales652.24484.14 35 2273.561935.29 17 OPM %26.9712.01 -21.8117.18 - PBDT181.7978.39 132 532.12405.00 31 PBT173.3671.96 141 501.92379.96 32 NP151.6784.92 79 433.82386.11 12
Powered by Capital Market - Live News
